What is the dosing of Immodium (Loperamide) for diarrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Loperamide (Immodium) Dosing for Diarrhea

For adults with acute diarrhea, start with 4 mg (two capsules) initially, followed by 2 mg (one capsule) after each unformed stool, with a maximum daily dose of 16 mg (eight capsules). 1

Standard Adult Dosing Algorithm

Initial Dose

  • 4 mg (two capsules) as a loading dose 2, 1
  • This loading dose is critical for achieving therapeutic effect more rapidly 2

Maintenance Dosing

  • 2 mg after each unformed stool 2, 1
  • Alternative schedule: 2 mg every 4 hours (particularly for cancer-related or complicated diarrhea) 2
  • Maximum: 16 mg per day (eight capsules) 2, 1

Important Timing Consideration

  • Allow 1-2 hours between doses for loperamide to reach therapeutic effect before taking additional doses to avoid rebound constipation 2

Pediatric Dosing (Ages 2-12 Years)

Loperamide is contraindicated in children under 2 years of age due to risks of respiratory depression and cardiac adverse reactions. 1

First Day Dosing by Age/Weight:

  • Ages 2-5 years (13-20 kg): 1 mg three times daily (3 mg total) 1
  • Ages 6-8 years (20-30 kg): 2 mg twice daily (4 mg total) 1
  • Ages 8-12 years (>30 kg): 2 mg three times daily (6 mg total) 1

Subsequent Days:

  • 1 mg per 10 kg body weight after each loose stool only 1
  • Do not exceed first-day maximum dosages 1

Context-Specific Dosing

Chronic Diarrhea

  • Start with 4 mg initially, then 2 mg after each unformed stool until controlled 1
  • Once controlled, reduce to maintenance dose of 4-8 mg daily (can be given as single daily dose) 1, 3
  • Maximum remains 16 mg per day 1
  • If no improvement after 10 days at 16 mg/day, further treatment unlikely to help 1

Cancer/Radiation-Induced Diarrhea

  • 4 mg initially, then 2 mg every 4 hours or after each unformed stool (maximum 16 mg/day) 2
  • Combine with oral hydration and dietary modifications (eliminate lactose, reduce insoluble fiber) 2

Traveler's Diarrhea (Mild)

  • 4 mg initially (two tablets), then 2 mg after each loose stool up to 16 mg/day 2
  • Reserve for mild diarrhea causing little interference with activities 2

Critical Safety Warnings

Absolute Contraindications - STOP Loperamide If:

  • Fever develops 2, 4
  • Moderate to severe abdominal pain occurs 2, 4
  • Bloody diarrhea appears 2, 4
  • Symptoms worsen despite treatment 2

Cardiac Risk

  • Never exceed 16 mg per day - higher doses increase risk of QT prolongation and Torsades de Pointes 4, 1
  • Avoid in elderly patients taking Class IA or III antiarrhythmics 1

Special Populations

  • Hepatic impairment: Use with caution; systemic exposure may increase due to reduced metabolism 1
  • Renal impairment: No dose adjustment needed 1
  • Elderly: No dose adjustment required, but increased susceptibility to QT effects 1

When to Escalate Treatment

  • If diarrhea persists beyond 48 hours without improvement, consider antibiotic therapy 1
  • For complicated diarrhea (with fever, dehydration, severe cramping), hospitalization and IV fluids may be needed alongside loperamide 2
  • Combination therapy with rifaximin provides faster resolution (27 hours vs 69 hours with loperamide alone) for traveler's diarrhea 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Loperamide treatment of the irritable bowel syndrome.

Scandinavian journal of gastroenterology. Supplement, 1987

Guideline

Loperamide Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.